节点文献

3种药物治疗高血压成本-效果分析

Cost-effectiveness Analysis of 3 Drugs in Treatment of Hypertension

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 任冠桦张峻陈文秀刘震

【Author】 REN Guan-hua,ZHANG Jun,CHEN Wen-xiu,LIU Zhen (1.The First Municipal People′s Hospital of Guangzhou,Department of Pharmacy;2.Department of Internal Medicine,Guangzhou,Guangdong 510180,China)

【机构】 广州市第一人民医院药剂科广州市第一人民医院内科

【摘要】 目的评价3种药物治疗高血压的疗效及经济学效果。方法将233例高血压患者随机分成3组,A组给予厄贝沙坦,B组给予氯沙坦钾,C组给予非洛地平,观察各组疗效,并进行成本-效果分析。结果A、B、C组总有效率分别为:93.51%、91.03%、92.30%。成本-效果比分别为:264.27、387.15、172.91,A、B组相当于C组的增量成本-效果比分别为7233.06、-15173.23。结论C组方案较佳。

【Abstract】 Objective To compare the curative effects and pharmacoeconomical efficacy of 3 drugs in the treatment of hypertension. Methods A total of 233 cases of hypertension patients were randomly divided into 3 groups,group A treated with irbesartan,group B treated with losartan potassium,and group C treated with felodipine.The curative effects in each group were observed,and the cost-effectiveness ratios were analyzed.Results The total effective rates of the 3 groups(A,B,and C) were 93.51%,91.03%,92.30%,respectively.The cost-effectiveness ratios were 264.27,387.15,and 172.91,respectively.The incremental cost-effectiveness ratios of group A and B against group C were 7233.06 and-15173.23,respectively.Conclusion The treatment of group C(Felodipine) is more reasonable.

  • 【分类号】R544.1
  • 【被引频次】5
  • 【下载频次】186
节点文献中: 

本文链接的文献网络图示:

本文的引文网络